Quest Diagnostics Inc (DGX) Slammed After Earnings, Here’s Where Its Going

This morning, leading diagnostic testing stock, Quest Diagnostics Inc (DGX), is getting slammed after issuing guidance. The medical services company is trading lower by more than 5.0% to $148.40 a share. Today, the stock broke below the important 50-day moving average. This puts the stock in a weak technical position in the near term. Quest Diagnostics Inc (GDX) stock has now declined by over $20.00 since the start of the new year and is now trending down. 

The next major support level for Quest Diagnostics Inc (GDX) stock will be around the $140.00 level. This support area is where the stock broke out to the upside in early November 2021. It is also where the 50-week moving average is currently and that should add strength to the support area. 

Get EVERY trade Nick is taking with his members right here…

Get all of Nick’s OPTIONS Swing Trades Here    <<>>    Get all of Nick’s STOCK Swing Trades Here